Eosinophils and immune mechanisms. II. Partial characterization of the lymphokine eosinophil stimulation promoter.
D000818:Animals; D000941:Antigens; D000961:Antilymphocyte Serum; D001202:Ascitic Fluid / Q000166:cytology; D002266:Carboxymethylcellulose Sodium / Q000494:pharmacology; D002464:Cell Migration Inhibition; D002465:Cell Movement; D002845:Chromatography; D002918:Chymotrypsin / Q000494:pharmacology; D003165:Complement System Proteins; D004531:Eggs; D004804:Eosinophils / Q000276:immunology*; D006168:Guinea Pigs / Q000276:immunology; D006358:Hot Temperature; D008198:Lymph Nodes / Q000166:cytology; D008222:Lymphokines / Q000096:biosynthesis*; D008263:Macrophage Migration-Inhibitory Factors; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D008970:Molecular Weight; D009439:Neuraminidase / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D012260:Ribonucleases / Q000494:pharmacology; D013154:Spleen / Q000166:cytology
D000941:Antigens; D000961:Antilymphocyte Serum; D008222:Lymphokines; D008263:Macrophage Migration-Inhibitory Factors; D011691:Puromycin; D003165:Complement System Proteins; D012260:Ribonucleases; D009439:Neuraminidase; D002918:Chymotrypsin; D002266:Carboxymethylcellulose Sodium